drugset / Trial / NCT01202214

Repeat Dose Safety Study for Compound to Treat Asthma

NCT01202214 ↗

Phase 1 Completed Accenture
RandomizedParallel-groupSingle-blindBasic science

Summary

The purpose of this study is to describe the safety and tolerability of single and repeat oral doses of GSK1440115 in healthy volunteers.

Timeline

Start
2010-09
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK1440115 Unknown — Oral

Indications